Darbejoy 40mcg Injection
Marketer
Sanzyme Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Darbejoy 40mcg Injection
Aranesp 40 mcg injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Use requires strict medical supervision due to potential severe adverse effects; expert medical management is essential. Adhere precisely to physician instructions; administration is exclusively under healthcare professional guidance. Common side effects comprise abdominal discomfort, hypertension, skin eruptions, injection site soreness, dyspnea, cough, and peripheral swelling. Report immediately any signs of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions. Regular blood tests will monitor electrolyte (potassium) levels, hemoglobin, and blood cell counts. Discontinue use and consult a physician if shortness of breath or rash develops. Prior to Aranesp 40 mcg injection, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals should obtain medical clearance.
Uses of Darbejoy 40mcg Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Darbejoy 40mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Darbejoy 40mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbejoy 40mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Darbejoy 40mcg Injection works:
Darbepoetin alfa 40 mcg injection is a medication that boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts on the bone marrow, prompting increased red blood cell formation within this blood-cell-generating tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbejoy 40mcg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbejoy 40mcg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Darbejoy 40mcg Injection while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Administration of Darbejoy 40mcg Injection typically does not impair driving capabilities.
KidneySAFE IF PRESCRIBED
Darbejoy 40mcg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
The administration of Darbejoy 40mcg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Darbejoy 40mcg Injection might be necessary. Physician consultation is advised.
What if you forget to take Darbejoy 40mcg Injection :
Should you forget a Darbejoy 40mcg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbejoy 40mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Type of Treatment | KINSHIP |
| Behavior Class | Erythropoietin-stimulating drug |
3,018 People bought this recently